nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—muscle cancer	0.71	1	CbGaD
Salicylate-sodium—PTGS2—Etoposide—muscle cancer	0.109	0.542	CbGbCtD
Salicylate-sodium—PTGS1—Etoposide—muscle cancer	0.0924	0.458	CbGbCtD
Salicylate-sodium—Acetylsalicylic acid—TP53—muscle cancer	0.00289	0.464	CrCbGaD
Salicylate-sodium—Hypocalcaemia—Dactinomycin—muscle cancer	0.00104	0.0126	CcSEcCtD
Salicylate-sodium—Ulcer—Dactinomycin—muscle cancer	0.00101	0.0122	CcSEcCtD
Salicylate-sodium—Extravasation—Vincristine—muscle cancer	0.000975	0.0118	CcSEcCtD
Salicylate-sodium—Cyanosis—Etoposide—muscle cancer	0.000973	0.0118	CcSEcCtD
Salicylate-sodium—Magnesium salicylate—PTGS2—muscle cancer	0.00089	0.143	CrCbGaD
Salicylate-sodium—Necrosis—Etoposide—muscle cancer	0.000878	0.0107	CcSEcCtD
Salicylate-sodium—Oesophagitis—Dactinomycin—muscle cancer	0.00087	0.0106	CcSEcCtD
Salicylate-sodium—Tingling sensation—Etoposide—muscle cancer	0.000857	0.0104	CcSEcCtD
Salicylate-sodium—Sepsis—Dactinomycin—muscle cancer	0.000826	0.01	CcSEcCtD
Salicylate-sodium—Phlebitis—Dactinomycin—muscle cancer	0.000802	0.00974	CcSEcCtD
Salicylate-sodium—Extravasation—Etoposide—muscle cancer	0.00079	0.00959	CcSEcCtD
Salicylate-sodium—Cellulitis—Etoposide—muscle cancer	0.000758	0.0092	CcSEcCtD
Salicylate-sodium—Salsalate—PTGS2—muscle cancer	0.000757	0.122	CrCbGaD
Salicylate-sodium—Ulcer—Etoposide—muscle cancer	0.000728	0.00885	CcSEcCtD
Salicylate-sodium—Lethargy—Dactinomycin—muscle cancer	0.000705	0.00856	CcSEcCtD
Salicylate-sodium—Deafness—Vincristine—muscle cancer	0.00069	0.00838	CcSEcCtD
Salicylate-sodium—Hypernatraemia—Doxorubicin—muscle cancer	0.00068	0.00825	CcSEcCtD
Salicylate-sodium—Venous thrombosis—Doxorubicin—muscle cancer	0.000662	0.00804	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Etoposide—muscle cancer	0.000658	0.00799	CcSEcCtD
Salicylate-sodium—Mesalazine—PTGS2—muscle cancer	0.000657	0.105	CrCbGaD
Salicylate-sodium—Oesophagitis—Etoposide—muscle cancer	0.00063	0.00765	CcSEcCtD
Salicylate-sodium—Gastric ulcer—Doxorubicin—muscle cancer	0.000615	0.00747	CcSEcCtD
Salicylate-sodium—Sepsis—Etoposide—muscle cancer	0.000598	0.00726	CcSEcCtD
Salicylate-sodium—Dysphagia—Dactinomycin—muscle cancer	0.000597	0.00725	CcSEcCtD
Salicylate-sodium—Burning sensation—Methotrexate—muscle cancer	0.000594	0.00721	CcSEcCtD
Salicylate-sodium—Cyanosis—Methotrexate—muscle cancer	0.000583	0.00708	CcSEcCtD
Salicylate-sodium—Phlebitis—Etoposide—muscle cancer	0.000581	0.00705	CcSEcCtD
Salicylate-sodium—Dehydration—Vincristine—muscle cancer	0.000574	0.00697	CcSEcCtD
Salicylate-sodium—Swelling—Etoposide—muscle cancer	0.000567	0.00689	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—muscle cancer	0.000565	0.0908	CrCbGaD
Salicylate-sodium—Cardiac failure congestive—Etoposide—muscle cancer	0.000552	0.0067	CcSEcCtD
Salicylate-sodium—Necrosis—Methotrexate—muscle cancer	0.000526	0.00639	CcSEcCtD
Salicylate-sodium—Abscess—Methotrexate—muscle cancer	0.000522	0.00633	CcSEcCtD
Salicylate-sodium—Burning sensation—Doxorubicin—muscle cancer	0.000514	0.00625	CcSEcCtD
Salicylate-sodium—Hepatitis—Dactinomycin—muscle cancer	0.000478	0.00581	CcSEcCtD
Salicylate-sodium—Extravasation—Methotrexate—muscle cancer	0.000473	0.00574	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Vincristine—muscle cancer	0.000469	0.0057	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Vincristine—muscle cancer	0.000466	0.00566	CcSEcCtD
Salicylate-sodium—Salicylic acid—PTGS2—muscle cancer	0.000466	0.0748	CrCbGaD
Salicylate-sodium—Necrosis—Doxorubicin—muscle cancer	0.000455	0.00553	CcSEcCtD
Salicylate-sodium—Feeling hot—Doxorubicin—muscle cancer	0.000455	0.00553	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Dactinomycin—muscle cancer	0.000452	0.00549	CcSEcCtD
Salicylate-sodium—Abscess—Doxorubicin—muscle cancer	0.000452	0.00549	CcSEcCtD
Salicylate-sodium—Oliguria—Methotrexate—muscle cancer	0.000448	0.00544	CcSEcCtD
Salicylate-sodium—Stinging—Doxorubicin—muscle cancer	0.000441	0.00536	CcSEcCtD
Salicylate-sodium—Ulcer—Methotrexate—muscle cancer	0.000436	0.0053	CcSEcCtD
Salicylate-sodium—Dysphagia—Etoposide—muscle cancer	0.000432	0.00525	CcSEcCtD
Salicylate-sodium—Bronchospasm—Etoposide—muscle cancer	0.000425	0.00516	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Vincristine—muscle cancer	0.000425	0.00516	CcSEcCtD
Salicylate-sodium—Hallucination—Vincristine—muscle cancer	0.000425	0.00516	CcSEcCtD
Salicylate-sodium—Sweating increased—Etoposide—muscle cancer	0.000421	0.00511	CcSEcCtD
Salicylate-sodium—Erythema—Dactinomycin—muscle cancer	0.000416	0.00505	CcSEcCtD
Salicylate-sodium—Extravasation—Doxorubicin—muscle cancer	0.00041	0.00497	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Methotrexate—muscle cancer	0.000394	0.00479	CcSEcCtD
Salicylate-sodium—Cellulitis—Doxorubicin—muscle cancer	0.000393	0.00477	CcSEcCtD
Salicylate-sodium—Hypocalcaemia—Doxorubicin—muscle cancer	0.00039	0.00474	CcSEcCtD
Salicylate-sodium—Oliguria—Doxorubicin—muscle cancer	0.000388	0.00471	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Etoposide—muscle cancer	0.00038	0.00461	CcSEcCtD
Salicylate-sodium—Renal failure—Etoposide—muscle cancer	0.000379	0.0046	CcSEcCtD
Salicylate-sodium—Ulcer—Doxorubicin—muscle cancer	0.000378	0.00459	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Etoposide—muscle cancer	0.000378	0.00459	CcSEcCtD
Salicylate-sodium—Creatinine increased—Doxorubicin—muscle cancer	0.000375	0.00456	CcSEcCtD
Salicylate-sodium—Ecchymosis—Methotrexate—muscle cancer	0.000373	0.00453	CcSEcCtD
Salicylate-sodium—Sepsis—Methotrexate—muscle cancer	0.000358	0.00435	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Etoposide—muscle cancer	0.000344	0.00418	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Doxorubicin—muscle cancer	0.000341	0.00414	CcSEcCtD
Salicylate-sodium—Oedema—Dactinomycin—muscle cancer	0.00034	0.00412	CcSEcCtD
Salicylate-sodium—Fluid retention—Doxorubicin—muscle cancer	0.000339	0.00412	CcSEcCtD
Salicylate-sodium—Infection—Dactinomycin—muscle cancer	0.000337	0.0041	CcSEcCtD
Salicylate-sodium—Blood urea increased—Doxorubicin—muscle cancer	0.000337	0.0041	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Etoposide—muscle cancer	0.000327	0.00397	CcSEcCtD
Salicylate-sodium—Oesophagitis—Doxorubicin—muscle cancer	0.000327	0.00397	CcSEcCtD
Salicylate-sodium—Renal failure acute—Methotrexate—muscle cancer	0.000325	0.00394	CcSEcCtD
Salicylate-sodium—Anorexia—Dactinomycin—muscle cancer	0.000324	0.00393	CcSEcCtD
Salicylate-sodium—Ecchymosis—Doxorubicin—muscle cancer	0.000323	0.00392	CcSEcCtD
Salicylate-sodium—Convulsion—Vincristine—muscle cancer	0.000322	0.00391	CcSEcCtD
Salicylate-sodium—Sepsis—Doxorubicin—muscle cancer	0.00031	0.00377	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Methotrexate—muscle cancer	0.000306	0.00371	CcSEcCtD
Salicylate-sodium—Lethargy—Methotrexate—muscle cancer	0.000306	0.00371	CcSEcCtD
Salicylate-sodium—Oedema—Vincristine—muscle cancer	0.000303	0.00369	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Vincristine—muscle cancer	0.000303	0.00369	CcSEcCtD
Salicylate-sodium—Infection—Vincristine—muscle cancer	0.000301	0.00366	CcSEcCtD
Salicylate-sodium—Phlebitis—Doxorubicin—muscle cancer	0.000301	0.00366	CcSEcCtD
Salicylate-sodium—Decreased appetite—Dactinomycin—muscle cancer	0.000295	0.00359	CcSEcCtD
Salicylate-sodium—Dysgeusia—Etoposide—muscle cancer	0.000295	0.00358	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Vincristine—muscle cancer	0.000293	0.00356	CcSEcCtD
Salicylate-sodium—Fatigue—Dactinomycin—muscle cancer	0.000293	0.00356	CcSEcCtD
Salicylate-sodium—Pain—Dactinomycin—muscle cancer	0.00029	0.00353	CcSEcCtD
Salicylate-sodium—Anorexia—Vincristine—muscle cancer	0.000289	0.00351	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000286	0.00347	CcSEcCtD
Salicylate-sodium—Irritability—Methotrexate—muscle cancer	0.000286	0.00347	CcSEcCtD
Salicylate-sodium—Hypotension—Vincristine—muscle cancer	0.000284	0.00344	CcSEcCtD
Salicylate-sodium—Renal failure acute—Doxorubicin—muscle cancer	0.000281	0.00341	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Dactinomycin—muscle cancer	0.00028	0.0034	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000278	0.00337	CcSEcCtD
Salicylate-sodium—Renal impairment—Doxorubicin—muscle cancer	0.000273	0.00331	CcSEcCtD
Salicylate-sodium—Paraesthesia—Vincristine—muscle cancer	0.000273	0.00331	CcSEcCtD
Salicylate-sodium—Abdominal pain—Dactinomycin—muscle cancer	0.000269	0.00326	CcSEcCtD
Salicylate-sodium—Body temperature increased—Dactinomycin—muscle cancer	0.000269	0.00326	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Etoposide—muscle cancer	0.000265	0.00322	CcSEcCtD
Salicylate-sodium—Lethargy—Doxorubicin—muscle cancer	0.000265	0.00321	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000265	0.00321	CcSEcCtD
Salicylate-sodium—Decreased appetite—Vincristine—muscle cancer	0.000264	0.0032	CcSEcCtD
Salicylate-sodium—Fatigue—Vincristine—muscle cancer	0.000262	0.00318	CcSEcCtD
Salicylate-sodium—Convulsion—Etoposide—muscle cancer	0.000261	0.00317	CcSEcCtD
Salicylate-sodium—Pain—Vincristine—muscle cancer	0.00026	0.00315	CcSEcCtD
Salicylate-sodium—Constipation—Vincristine—muscle cancer	0.00026	0.00315	CcSEcCtD
Salicylate-sodium—Asthma—Methotrexate—muscle cancer	0.000259	0.00314	CcSEcCtD
Salicylate-sodium—Chest pain—Etoposide—muscle cancer	0.000256	0.00311	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Dactinomycin—muscle cancer	0.00025	0.00304	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Methotrexate—muscle cancer	0.000248	0.00301	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Vincristine—muscle cancer	0.000248	0.00301	CcSEcCtD
Salicylate-sodium—Confusional state—Etoposide—muscle cancer	0.000248	0.00301	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Etoposide—muscle cancer	0.000246	0.00299	CcSEcCtD
Salicylate-sodium—Infection—Etoposide—muscle cancer	0.000244	0.00297	CcSEcCtD
Salicylate-sodium—Asthenia—Dactinomycin—muscle cancer	0.000244	0.00296	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Doxorubicin—muscle cancer	0.000243	0.00295	CcSEcCtD
Salicylate-sodium—Dehydration—Doxorubicin—muscle cancer	0.000241	0.00293	CcSEcCtD
Salicylate-sodium—Tachycardia—Etoposide—muscle cancer	0.00024	0.00291	CcSEcCtD
Salicylate-sodium—Abdominal pain—Vincristine—muscle cancer	0.00024	0.00291	CcSEcCtD
Salicylate-sodium—Body temperature increased—Vincristine—muscle cancer	0.00024	0.00291	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Etoposide—muscle cancer	0.000238	0.00289	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Doxorubicin—muscle cancer	0.000237	0.00288	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Doxorubicin—muscle cancer	0.000236	0.00287	CcSEcCtD
Salicylate-sodium—Anorexia—Etoposide—muscle cancer	0.000234	0.00285	CcSEcCtD
Salicylate-sodium—Diarrhoea—Dactinomycin—muscle cancer	0.000232	0.00282	CcSEcCtD
Salicylate-sodium—Drowsiness—Methotrexate—muscle cancer	0.000231	0.0028	CcSEcCtD
Salicylate-sodium—Hypotension—Etoposide—muscle cancer	0.00023	0.00279	CcSEcCtD
Salicylate-sodium—Renal failure—Methotrexate—muscle cancer	0.000227	0.00276	CcSEcCtD
Salicylate-sodium—Abdominal distension—Doxorubicin—muscle cancer	0.000226	0.00274	CcSEcCtD
Salicylate-sodium—Dysphagia—Doxorubicin—muscle cancer	0.000224	0.00272	CcSEcCtD
Salicylate-sodium—Asthma—Doxorubicin—muscle cancer	0.000224	0.00272	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Vincristine—muscle cancer	0.000224	0.00272	CcSEcCtD
Salicylate-sodium—Paraesthesia—Etoposide—muscle cancer	0.000221	0.00268	CcSEcCtD
Salicylate-sodium—Dyspnoea—Etoposide—muscle cancer	0.000219	0.00266	CcSEcCtD
Salicylate-sodium—Somnolence—Etoposide—muscle cancer	0.000219	0.00265	CcSEcCtD
Salicylate-sodium—Epistaxis—Methotrexate—muscle cancer	0.000218	0.00264	CcSEcCtD
Salicylate-sodium—Asthenia—Vincristine—muscle cancer	0.000218	0.00264	CcSEcCtD
Salicylate-sodium—Vomiting—Dactinomycin—muscle cancer	0.000216	0.00262	CcSEcCtD
Salicylate-sodium—Bronchitis—Doxorubicin—muscle cancer	0.000216	0.00262	CcSEcCtD
Salicylate-sodium—Rash—Dactinomycin—muscle cancer	0.000214	0.0026	CcSEcCtD
Salicylate-sodium—Decreased appetite—Etoposide—muscle cancer	0.000214	0.0026	CcSEcCtD
Salicylate-sodium—Fatigue—Etoposide—muscle cancer	0.000212	0.00257	CcSEcCtD
Salicylate-sodium—Pain—Etoposide—muscle cancer	0.00021	0.00255	CcSEcCtD
Salicylate-sodium—Constipation—Etoposide—muscle cancer	0.00021	0.00255	CcSEcCtD
Salicylate-sodium—Diarrhoea—Vincristine—muscle cancer	0.000208	0.00252	CcSEcCtD
Salicylate-sodium—Hepatitis—Methotrexate—muscle cancer	0.000207	0.00252	CcSEcCtD
Salicylate-sodium—Weight increased—Doxorubicin—muscle cancer	0.000204	0.00248	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Etoposide—muscle cancer	0.000203	0.00246	CcSEcCtD
Salicylate-sodium—Nausea—Dactinomycin—muscle cancer	0.000202	0.00245	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Etoposide—muscle cancer	0.000201	0.00244	CcSEcCtD
Salicylate-sodium—Dizziness—Vincristine—muscle cancer	0.000201	0.00244	CcSEcCtD
Salicylate-sodium—Drowsiness—Doxorubicin—muscle cancer	0.0002	0.00243	CcSEcCtD
Salicylate-sodium—Renal failure—Doxorubicin—muscle cancer	0.000197	0.00239	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Methotrexate—muscle cancer	0.000196	0.00238	CcSEcCtD
Salicylate-sodium—Urticaria—Etoposide—muscle cancer	0.000195	0.00237	CcSEcCtD
Salicylate-sodium—Abdominal pain—Etoposide—muscle cancer	0.000194	0.00236	CcSEcCtD
Salicylate-sodium—Body temperature increased—Etoposide—muscle cancer	0.000194	0.00236	CcSEcCtD
Salicylate-sodium—Tinnitus—Methotrexate—muscle cancer	0.000193	0.00235	CcSEcCtD
Salicylate-sodium—Vomiting—Vincristine—muscle cancer	0.000193	0.00234	CcSEcCtD
Salicylate-sodium—Rash—Vincristine—muscle cancer	0.000191	0.00232	CcSEcCtD
Salicylate-sodium—Dermatitis—Vincristine—muscle cancer	0.000191	0.00232	CcSEcCtD
Salicylate-sodium—Headache—Vincristine—muscle cancer	0.00019	0.00231	CcSEcCtD
Salicylate-sodium—Epistaxis—Doxorubicin—muscle cancer	0.000189	0.00229	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Etoposide—muscle cancer	0.000181	0.0022	CcSEcCtD
Salicylate-sodium—Erythema—Methotrexate—muscle cancer	0.00018	0.00219	CcSEcCtD
Salicylate-sodium—Nausea—Vincristine—muscle cancer	0.00018	0.00219	CcSEcCtD
Salicylate-sodium—Hepatitis—Doxorubicin—muscle cancer	0.000179	0.00218	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Doxorubicin—muscle cancer	0.000179	0.00217	CcSEcCtD
Salicylate-sodium—Dysgeusia—Methotrexate—muscle cancer	0.000177	0.00215	CcSEcCtD
Salicylate-sodium—Asthenia—Etoposide—muscle cancer	0.000176	0.00214	CcSEcCtD
Salicylate-sodium—Pruritus—Etoposide—muscle cancer	0.000174	0.00211	CcSEcCtD
Salicylate-sodium—Vision blurred—Methotrexate—muscle cancer	0.00017	0.00206	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Doxorubicin—muscle cancer	0.00017	0.00206	CcSEcCtD
Salicylate-sodium—Diarrhoea—Etoposide—muscle cancer	0.000168	0.00204	CcSEcCtD
Salicylate-sodium—Tinnitus—Doxorubicin—muscle cancer	0.000167	0.00203	CcSEcCtD
Salicylate-sodium—Dizziness—Etoposide—muscle cancer	0.000163	0.00197	CcSEcCtD
Salicylate-sodium—Arrhythmia—Doxorubicin—muscle cancer	0.00016	0.00195	CcSEcCtD
Salicylate-sodium—Convulsion—Methotrexate—muscle cancer	0.000156	0.0019	CcSEcCtD
Salicylate-sodium—Vomiting—Etoposide—muscle cancer	0.000156	0.0019	CcSEcCtD
Salicylate-sodium—Erythema—Doxorubicin—muscle cancer	0.000156	0.0019	CcSEcCtD
Salicylate-sodium—Rash—Etoposide—muscle cancer	0.000155	0.00188	CcSEcCtD
Salicylate-sodium—Dermatitis—Etoposide—muscle cancer	0.000155	0.00188	CcSEcCtD
Salicylate-sodium—Headache—Etoposide—muscle cancer	0.000154	0.00187	CcSEcCtD
Salicylate-sodium—Flatulence—Doxorubicin—muscle cancer	0.000154	0.00187	CcSEcCtD
Salicylate-sodium—Chest pain—Methotrexate—muscle cancer	0.000154	0.00187	CcSEcCtD
Salicylate-sodium—Dysgeusia—Doxorubicin—muscle cancer	0.000153	0.00186	CcSEcCtD
Salicylate-sodium—Confusional state—Methotrexate—muscle cancer	0.000148	0.0018	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Methotrexate—muscle cancer	0.000147	0.00179	CcSEcCtD
Salicylate-sodium—Vision blurred—Doxorubicin—muscle cancer	0.000147	0.00179	CcSEcCtD
Salicylate-sodium—Infection—Methotrexate—muscle cancer	0.000146	0.00178	CcSEcCtD
Salicylate-sodium—Nausea—Etoposide—muscle cancer	0.000146	0.00177	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Methotrexate—muscle cancer	0.000142	0.00173	CcSEcCtD
Salicylate-sodium—Anorexia—Methotrexate—muscle cancer	0.00014	0.0017	CcSEcCtD
Salicylate-sodium—Syncope—Doxorubicin—muscle cancer	0.00014	0.0017	CcSEcCtD
Salicylate-sodium—Palpitations—Doxorubicin—muscle cancer	0.000138	0.00168	CcSEcCtD
Salicylate-sodium—Hypotension—Methotrexate—muscle cancer	0.000138	0.00167	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Doxorubicin—muscle cancer	0.000137	0.00167	CcSEcCtD
Salicylate-sodium—Convulsion—Doxorubicin—muscle cancer	0.000135	0.00164	CcSEcCtD
Salicylate-sodium—Chest pain—Doxorubicin—muscle cancer	0.000133	0.00162	CcSEcCtD
Salicylate-sodium—Anxiety—Doxorubicin—muscle cancer	0.000133	0.00161	CcSEcCtD
Salicylate-sodium—Paraesthesia—Methotrexate—muscle cancer	0.000132	0.00161	CcSEcCtD
Salicylate-sodium—Dyspnoea—Methotrexate—muscle cancer	0.000131	0.00159	CcSEcCtD
Salicylate-sodium—Somnolence—Methotrexate—muscle cancer	0.000131	0.00159	CcSEcCtD
Salicylate-sodium—Dyspepsia—Methotrexate—muscle cancer	0.00013	0.00157	CcSEcCtD
Salicylate-sodium—Confusional state—Doxorubicin—muscle cancer	0.000129	0.00156	CcSEcCtD
Salicylate-sodium—Decreased appetite—Methotrexate—muscle cancer	0.000128	0.00155	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Doxorubicin—muscle cancer	0.000128	0.00155	CcSEcCtD
Salicylate-sodium—Oedema—Doxorubicin—muscle cancer	0.000128	0.00155	CcSEcCtD
Salicylate-sodium—Fatigue—Methotrexate—muscle cancer	0.000127	0.00154	CcSEcCtD
Salicylate-sodium—Infection—Doxorubicin—muscle cancer	0.000127	0.00154	CcSEcCtD
Salicylate-sodium—Pain—Methotrexate—muscle cancer	0.000126	0.00153	CcSEcCtD
Salicylate-sodium—Shock—Doxorubicin—muscle cancer	0.000125	0.00152	CcSEcCtD
Salicylate-sodium—Tachycardia—Doxorubicin—muscle cancer	0.000124	0.00151	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Doxorubicin—muscle cancer	0.000123	0.0015	CcSEcCtD
Salicylate-sodium—Anorexia—Doxorubicin—muscle cancer	0.000122	0.00148	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Methotrexate—muscle cancer	0.000121	0.00147	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Methotrexate—muscle cancer	0.00012	0.00146	CcSEcCtD
Salicylate-sodium—Hypotension—Doxorubicin—muscle cancer	0.000119	0.00145	CcSEcCtD
Salicylate-sodium—Urticaria—Methotrexate—muscle cancer	0.000117	0.00142	CcSEcCtD
Salicylate-sodium—Body temperature increased—Methotrexate—muscle cancer	0.000116	0.00141	CcSEcCtD
Salicylate-sodium—Abdominal pain—Methotrexate—muscle cancer	0.000116	0.00141	CcSEcCtD
Salicylate-sodium—Paraesthesia—Doxorubicin—muscle cancer	0.000114	0.00139	CcSEcCtD
Salicylate-sodium—Dyspnoea—Doxorubicin—muscle cancer	0.000114	0.00138	CcSEcCtD
Salicylate-sodium—Somnolence—Doxorubicin—muscle cancer	0.000113	0.00138	CcSEcCtD
Salicylate-sodium—Dyspepsia—Doxorubicin—muscle cancer	0.000112	0.00136	CcSEcCtD
Salicylate-sodium—Decreased appetite—Doxorubicin—muscle cancer	0.000111	0.00135	CcSEcCtD
Salicylate-sodium—Fatigue—Doxorubicin—muscle cancer	0.00011	0.00133	CcSEcCtD
Salicylate-sodium—Pain—Doxorubicin—muscle cancer	0.000109	0.00132	CcSEcCtD
Salicylate-sodium—Constipation—Doxorubicin—muscle cancer	0.000109	0.00132	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Methotrexate—muscle cancer	0.000108	0.00132	CcSEcCtD
Salicylate-sodium—Asthenia—Methotrexate—muscle cancer	0.000106	0.00128	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Doxorubicin—muscle cancer	0.000105	0.00128	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000104	0.00127	CcSEcCtD
Salicylate-sodium—Pruritus—Methotrexate—muscle cancer	0.000104	0.00127	CcSEcCtD
Salicylate-sodium—Urticaria—Doxorubicin—muscle cancer	0.000101	0.00123	CcSEcCtD
Salicylate-sodium—Body temperature increased—Doxorubicin—muscle cancer	0.000101	0.00122	CcSEcCtD
Salicylate-sodium—Abdominal pain—Doxorubicin—muscle cancer	0.000101	0.00122	CcSEcCtD
Salicylate-sodium—Diarrhoea—Methotrexate—muscle cancer	0.000101	0.00122	CcSEcCtD
Salicylate-sodium—Dizziness—Methotrexate—muscle cancer	9.74e-05	0.00118	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Doxorubicin—muscle cancer	9.39e-05	0.00114	CcSEcCtD
Salicylate-sodium—Vomiting—Methotrexate—muscle cancer	9.36e-05	0.00114	CcSEcCtD
Salicylate-sodium—Rash—Methotrexate—muscle cancer	9.28e-05	0.00113	CcSEcCtD
Salicylate-sodium—Dermatitis—Methotrexate—muscle cancer	9.28e-05	0.00113	CcSEcCtD
Salicylate-sodium—Headache—Methotrexate—muscle cancer	9.22e-05	0.00112	CcSEcCtD
Salicylate-sodium—Asthenia—Doxorubicin—muscle cancer	9.15e-05	0.00111	CcSEcCtD
Salicylate-sodium—Pruritus—Doxorubicin—muscle cancer	9.02e-05	0.0011	CcSEcCtD
Salicylate-sodium—Nausea—Methotrexate—muscle cancer	8.75e-05	0.00106	CcSEcCtD
Salicylate-sodium—Diarrhoea—Doxorubicin—muscle cancer	8.72e-05	0.00106	CcSEcCtD
Salicylate-sodium—Dizziness—Doxorubicin—muscle cancer	8.43e-05	0.00102	CcSEcCtD
Salicylate-sodium—Vomiting—Doxorubicin—muscle cancer	8.11e-05	0.000985	CcSEcCtD
Salicylate-sodium—Rash—Doxorubicin—muscle cancer	8.04e-05	0.000976	CcSEcCtD
Salicylate-sodium—Dermatitis—Doxorubicin—muscle cancer	8.03e-05	0.000975	CcSEcCtD
Salicylate-sodium—Headache—Doxorubicin—muscle cancer	7.99e-05	0.00097	CcSEcCtD
Salicylate-sodium—Nausea—Doxorubicin—muscle cancer	7.57e-05	0.00092	CcSEcCtD
